223 related articles for article (PubMed ID: 24628238)
21. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
22. Antitumoral alkylphospholipids alter cell lipid metabolism.
Marco C; Ríos-Marco P; Jiménez-López JM; Segovia JL; Carrasco MP
Anticancer Agents Med Chem; 2014 May; 14(4):545-58. PubMed ID: 24628237
[TBL] [Abstract][Full Text] [Related]
23. Strategizing the clone wars: pharmacological control of cellular sensitivity to radiation.
Kimple RJ
Mol Interv; 2010 Dec; 10(6):341-53. PubMed ID: 21263160
[TBL] [Abstract][Full Text] [Related]
24. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy.
Jaffrès PA; Gajate C; Bouchet AM; Couthon-Gourvès H; Chantôme A; Potier-Cartereau M; Besson P; Bougnoux P; Mollinedo F; Vandier C
Pharmacol Ther; 2016 Sep; 165():114-31. PubMed ID: 27288726
[TBL] [Abstract][Full Text] [Related]
25. Current view on the mechanism of action of perifosine in cancer.
Fensterle J; Aicher B; Seipelt I; Teifel M; Engel J
Anticancer Agents Med Chem; 2014 May; 14(4):629-35. PubMed ID: 24628236
[TBL] [Abstract][Full Text] [Related]
26. Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation.
Pauwels B; Wouters A; Peeters M; Vermorken JB; Lardon F
Future Oncol; 2010 Sep; 6(9):1485-96. PubMed ID: 20919831
[TBL] [Abstract][Full Text] [Related]
27. Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy.
Ding M; Zhang E; He R; Wang X
Cancer Sci; 2013 Nov; 104(11):1401-10. PubMed ID: 23930697
[TBL] [Abstract][Full Text] [Related]
28. Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine.
Villa-Pulgarín JA; Gajate C; Botet J; Jimenez A; Justies N; Varela-M RE; Cuesta-Marbán Á; Müller I; Modolell M; Revuelta JL; Mollinedo F
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005805. PubMed ID: 28829771
[TBL] [Abstract][Full Text] [Related]
29. The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers.
Salehifar E; Hosseinimehr SJ
Drug Discov Today; 2016 Apr; 21(4):654-62. PubMed ID: 26955911
[TBL] [Abstract][Full Text] [Related]
30. Lipid rafts, endoplasmic reticulum and mitochondria in the antitumor action of the alkylphospholipid analog edelfosine.
Gajate C; Mollinedo F
Anticancer Agents Med Chem; 2014 May; 14(4):509-27. PubMed ID: 24628241
[TBL] [Abstract][Full Text] [Related]
31. Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Coleman CN
Semin Oncol; 1989 Jun; 16(3):169-75. PubMed ID: 2658080
[No Abstract] [Full Text] [Related]
32. Antitumor Lipids--Structure, Functions, and Medical Applications.
Kostadinova A; Topouzova-Hristova T; Momchilova A; Tzoneva R; Berger MR
Adv Protein Chem Struct Biol; 2015; 101():27-66. PubMed ID: 26572975
[TBL] [Abstract][Full Text] [Related]
33. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
Bentzen SM; Harari PM; Bernier J
Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
[TBL] [Abstract][Full Text] [Related]
34. In Vitro and In Vivo Studies of a New Class of Anticancer Molecules for Targeted Radiotherapy of Cancer.
Wang CR; Mahmood J; Zhang QR; Vedadi A; Warrington J; Ou N; Bristow RG; Jaffray DA; Lu QB
Mol Cancer Ther; 2016 Apr; 15(4):640-50. PubMed ID: 26921393
[TBL] [Abstract][Full Text] [Related]
35. In vitro and In vivo selective antitumor activity of Edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid rafts.
Mollinedo F; de la Iglesia-Vicente J; Gajate C; Estella-Hermoso de Mendoza A; Villa-Pulgarin JA; de Frias M; Roué G; Gil J; Colomer D; Campanero MA; Blanco-Prieto MJ
Clin Cancer Res; 2010 Apr; 16(7):2046-54. PubMed ID: 20233887
[TBL] [Abstract][Full Text] [Related]
36. Alkylphospholipids are Signal Transduction Modulators with Potential for Anticancer Therapy.
Kaleağasıoğlu F; Zaharieva MM; Konstantinov SM; Berger MR
Anticancer Agents Med Chem; 2019; 19(1):66-91. PubMed ID: 30318001
[TBL] [Abstract][Full Text] [Related]
37. Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol.
Komorowska D; Radzik T; Kalenik S; Rodacka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142554
[TBL] [Abstract][Full Text] [Related]
38. Selective pharmacologic inhibition of c-Jun NH2-terminal kinase radiosensitizes thyroid anaplastic cancer cell lines via induction of terminal growth arrest.
Bulgin D; Podtcheko A; Takakura S; Mitsutake N; Namba H; Saenko V; Ohtsuru A; Rogounovitch T; Palona I; Yamashita S
Thyroid; 2006 Mar; 16(3):217-24. PubMed ID: 16571083
[TBL] [Abstract][Full Text] [Related]
39. Apoptosis-modulating agents in combination with radiotherapy-current status and outlook.
Belka C; Jendrossek V; Pruschy M; Vink S; Verheij M; Budach W
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):542-54. PubMed ID: 14751526
[TBL] [Abstract][Full Text] [Related]
40. Targeting IAP proteins in combination with radiotherapy.
Fulda S
Radiat Oncol; 2015 Apr; 10():105. PubMed ID: 25927408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
